It was previously reported that prosaposin pos sesses neurotrophic activity that is ascribed to an IS-mer pep tide comprising the hydrophilic sequence of the rat saposin C domain. To evaluate the effect of the IS-mer peptide on isch emic neuronal damage, the peptide was infused in the left lat eral ventricle immediately after occlusion of the left middle cerebral artery (MCA) in stroke-prone spontaneously hyperten sive (SP-SH) rats. The treatment ameliorated the ischemia induced space navigation disability and cortical infarction and prevented secondary thalamic degeneration in a dose dependent manner. In culture experiments, treatment with the IS-mer peptide attenuated free radical-induced neuronal injury at low concentrations (0,002 to 2 pg/mL), and the peptide at
Prosaposin, the precursor of saposins A, B, C, and D, which activate sphingolipid hydro lases in lysosomes, is a 517-amino acid glycoprotein (O'Brien and Kishimoto, 199 1; Kishimoto et aI., 1992) , Besides its role as the precursor of saposins in lysosome, prosaposin itself ex ists as a secretory protein in human milk, cerebrospinal fluid, and seminal plasma (Hineno et aI., 199 1; Kondoh et aI., 1991; Hiraiwa et aI., 1993) . Prosaposin is abundant in brain and muscle, whereas processed saposins are pre-higher concentrations (0.2 to 20 ng/mL) protected neurons against hypoxic insult. Furthermore, a saposin C fragment com prising the IS-mer peptide bound to synaptosomal fractions of the cerebral cortex, and this binding decreased at the 1st day after MCA occlusion and recovered to the preischemic level at the 7th day after ischemia. These findings suggest that the IS-mer peptide ameliorates neuronal damage in vivo and in vitro through binding to the functional receptor, although the cDNA encoding prosaposin receptor has not been determined yet. Key Words: Prosaposin-lS-mer peptide-Middle cere bral artery occlusion-Morris water maze test-Cortical neu rons-Neurotrophic action.
dominantly found in spleen, liver, and kidney (O'Brien et aI., 1988; Sano et aI., 1989) . In the brain, prosaposin is localized exclusively in certain neurons and nerve fibers. Furthermore, prosaposin-containing neural elements are abundant in the CA 1 field of the hippocampus (Kondoh et aI., 1993) , which is known to be vulnerable to isch emic insult. With the use of a gerbil ischemia model, we have recently demonstrated that prosaposin has a potent ability to rescue hippocampal neurons from lethal isch emic damage in vivo (Sano et aI., 1994) , raising the pos sibility of prosaposin as a candidate for neurotrophic factor. The pivotal role of prosaposin in neurogenesis was also indicated by Harzer et aI. (1989) and Schnabel et aI. (1992) , who reported that pro sapos in deficiency causes fetal neurological deficits. O'Brien et aI. (1994 O'Brien et aI. ( , 1995 demonstrated that prosaposin stimulates neurito genesis and increases choline acetyltransferase activity in neuroblastoma cells and that the neurotrophic activity resides, at least in part, in an amino-terminal l2-residue peptide encompassing the hydrophilic region of the hu man saposin C domain. We further showed that an 18mer peptide comprising the hydrophilic sequence of the rat saposin C domain protects hippocampal CAl neurons against lethal forebrain ischemia in gerbils (Kotani et a!., 1996) . However, the mechanisms by which the 18-mer peptide rescues ischemic CA 1 neurons have not been elucidated yet.
The so-called delayed neuronal death in the hippocam pal CAl region of gerbils after transient forebrain isch emia has been a subject of investigation over decades, but other types of ischemic models have also been de veloped mainly by using rats of several species (Tamura et a!., 198 1; Coyle, 1982; Coyle and 10kelainen, 1983; Brint et a!., 1988; Okuyama et a!., 199 1) . Among them, stroke-prone spontaneously hypertensive (SP-SH) rats with permanent occlusion of the unilateral middle cere bral artery (MCA) above the rhinal fissure and distal to the striate branches exhibit invariably a certain cortical infarct, place navigation disability, and secondary tha lamic degeneration focused on the ventroposterior (VP) nucleus (Kumon et a!., 1996; Zhang et a!., 1998) . There fore, they appear to be an animal model suitable for the study of the effects of peptide growth factors and drugs on the primary ischemic lesion and on the secondary degeneration in brain areas connected synaptically with the primary lesion (Okuyama et a!., 199 1). There are several advantages of the MCA-occluded SP-SH rat model over the gerbil ischemia model. First, SP-SH rats subjected to p«rmanent occlusion of the MCA mimic human patients suffering from cerebral infarction as compared with gerbils with transient forebrain ischemia. Second, the observation of ischemia-induced behavioral abnormalities is easier in rats than in gerbils. Therefore, it is of interest to see the action of the 18-mer peptide on the brain of MCA-occluded SP-SH rats with a severer ischemic damage than gerbils subjected to transient fore brain ischemia.
The present study was designed first to see whether or not continuous infusion of the 18-mer peptide into the cerebral ventricles of MCA-occluded SP-SH rats, like ciliary neurotrophic factor (CNTF) (Kumon et a!., 1996) , ameliorated place navigation disability, cortical infarc tion, and secondary thalamic degeneration. Second, we investigated the effects of the I8-mer peptide on cultured cortical neurons exposed to a free radical-producing agent, FeS04, or to hypoxic environment. Finally, using the BIAcore system (Karlsson et a!., 199 1), we studied whether or not subcellular fractions of the cerebral cortex and thalamus in the MCA-occluded rats had binding el ements for the 18-mer peptide.
MATERIALS AND METHODS

Synthetic 1S-mer peptide
An 18-mer peptide (LSELIINNATEELLlKGL) comprising the hydrophilic sequence of rat saposin C was chemically syn thesized by Sawady Technology, Tokyo, Japan (Kotani et al., 1996) .
In vivo study SP-SH rats at the age of 12 to 13 weeks, weighing 250 to 300 g, were housed in an air-conditioned room at constant tempera ture (22 ± 1°C) with a 12: 12 light/dark cycle, and food and water were given ad libitum throughout the experiments. The animals were handled once a week for cage cleaning. The experiments were conducted in accordance with the Guide for Animal Experimentation at Ehime University School of Medi cine. Tail systolic blood pressure in each conscious animal was measured before MCA occlusion and at 2 hours, I to 7 days after MCA occlusion. with the use of a rat tail manometer tachometer system (KN-21O; Natsume, Tokyo, Japan). The mean blood pressure of SP-SH rats before MCA occlusion was 20 I ± 22 mm Hg, and it was not affected by MCA occlusion or 18-mer peptide infusion.
SP-SH rats were anesthetized with 1.5% halothane in a 4:3 mixture of nitrous oxide and oxygen, while body temperature was kept at 37 ± 0.2°C. The left MCA was exposed by cutting the temporal muscle and then by making a hole in the temporal bone with a dental drill. Just after MCA occlusion, an osmotic mini pump (Alza Corp., Palo Alto, CA, U.S.A.) filled with ei ther the 18-mer peptide or vehicle [0.01 mollL phosphate buffered saline (PBS) containing 0. 1 % bovine serum albumin (BSA)] was implanted subcutaneously into the back of each animal, and a needle from the minipump was placed in the left lateral ventricle. The 18-mer peptide in a dose of 4, 20, or 60 ng/day was continuously infused through the minipump for 28 days (n = 8/group). Sham-operated animals and control rats with MCA occlusion received vehicle infusion (n = 8/group).
Brain and body temperatures in rats infused with vehicle or 60 ng/day of the 18-mer peptide were monitored at the 1 st to 7th hours (n = 4/group). Body temperature was measured with a rectal probe connected to a digital thermometer (Y okogawa, Tokyo, Japan) just after diethylether anesthesia, and brain tem perature was monitored by combining a temperature-sensitive probe (Mini Mitter Co., Sunriver, OR, U.S.A.) inserted into the right frontal lobe (1.0 mm anterior to bregma, 1.5 mm lateral to the midline, and 2.5 mm in depth) with the telemetry system receiving signals from the probe (Data Sciences, Minneapolis, MN, U.S.A.).
At the 2nd and 4th weeks after MCA occlusion, the rats were subjected to repeated Morris water maze tests three times per day for 4 consecutive days. Each rat was allowed to swim until reaching a submerged platform and to stay there for at least 10 seconds. The escape latency, i.e., time until each rat reached the invisible submerged platform, was measured (Morris, 1981) . In the cases where the rats could not escape onto the platform within 90 seconds, they were placed by hand onto the platform for 15 seconds and their escape latency was recorded as 90 seconds. The mean latency of finding the invisible platform was measured for individual animals on each day.
After the water maze tests, the animals were anesthetized by an intraperitoneal injection of chloral hydrate (300 mg/kg), and the osmotic mini pump was disconnected from the needle placed in the left lateral ventricle. Bromophenol blue was in jected through the needle to test the peptide or vehicle infusion into the cerebral ventricles. Then the rats were perfused trans cardially with 4% paraformaldehyde in 0.1 mollL phosphate buffer (pH 7.4) and the brain was removed. The animals not showing dye diffusion into the cerebral ventricles were ex cluded from the experimental groups. The brain with dye dif fusion was embedded in paraffin. Three serial coronal sections 5 [Lm thick were cut at 1.2, 2.3, and 3.6 mm posterior to bregma and stained with 0.1 % cresyl violet. The size of cortical infarc tion was assessed by measuring the area of the cerebral cortex in individual sections with a planimeter, and the ratio of the cerebrocortical area on the MCA-occluded side to that on the contralateral side was calculated in the three sections. This was termed left -to-right cerebrocortical ratio.
To assess secondary thalamic atrophy, the ratio of thalamic area on the MCA-occluded side to that on the contralateral side was calculated in the section 3.6 mm posterior to bregma. The thalamus at this level is known to constitute reciprocal fiber connections with the temporoparietal cortex, and thus it is likely to exhibit secondary degeneration after MCA occlusion that causes an infarct in the temporoparietal cortex. The degen eration of neurons in the VP thalamic nucleus was evaluated microscopically by measuring the size of each cell with a com puterized image-processing system (Nexus 6400 System; Kashiwagi, Tokyo, Japan). A square of 0.33 ± 0.30 mm (510 ± 47S pixels) was designated as the region of interest on the video image, and the size of each cell within the square was measured and expressed by its pixel size. Cells larger than 200 pixels were counted as viable neurons (Kumon et a!., 1996; Watanabe et a!., 1995) .
All experiments were done blindly with respect to the ex perimental group.
Cortical neuron cultures
The cerebral cortices of 17-day rat embryos were aseptically dissected out, and cortical neurons were dissociated from the tissues as described by Kira et a!. (1995) . The dissociated cells were seeded on 24-well plastic plates (Corning, Corning, NY, U.S.A.) coated with polY-L-lysine (Sigma, St. Louis, MO, U.S.A.) at a density of I x 105 cells/cm 2 . The cells were cul tured at 37 , oC in Dulbecco's modified Eagle's medium (DMEM; 0.1 % glucose; Nipro, Osaka, Japan) supplemented with 10% fetal calf serum (Life Technologies, Rockville, MD, U.S.A.) under a humidified atmosphere containing 5% CO2 for 24 hours. Then the medium was replaced with a serum free DMEM containing graded concentrations (0.2 fg/mL to 200 ng/mL) of the IS-mer peptide, 20 mmollL N-(2hydroxyethyl)piperazine-N' ,2-ethanesulfonic acid (HEPES), 4.5 mglmL glucose, I mg/mL BSA, 5 mg/mL insulin, 5 nmol/L sodium selenite, and 5 mg/mL transferrin (Boehringer Mannheim, Mannheim, Germany). Forty-eight hours later, the neurons were subjected to free radical-induced injury (Lim et a!., 1997) . Briefly, 30 f.1mollL FeS04 was added to each well, and 1.5 hours later the neurons were solubilized with Laemmli's sample solution containing sodium dodecyl sulfate (Laemmli, 1970) and electrophoresed on a 6% polyacrylamide gel. The electrophoretic bands were transferred to nitrocellu lose sheets and immunoblotted with a monoclonal antibody (Sternberger Monoclonals, Baltimore, MD, U.S.A.) against mi crotubule-associated protein 2 (MAP2), which is known to be a specific marker for neuronal cells. Anti-mouse IgG coupled with alkaline phosphatase (Promega, Madison, WI, U.S.A.) was used for the second immunoreaction. The density of each MAP2-positive band was measured by NIH Image (National Institutes of Health, Bethesda, MD, U.S.A.).
To confirm the antioxidant action of the IS-mer peptide, we measured membrane lipid peroxidation of neurons treated with the IS-mer peptide and FeS04. Cortical neurons were seeded on 35-mm-diameter dishes (Sumitomo, Tokyo, Japan) at a den sity of 1 x 105 cells/cm 2 , pretreated with 2 fg/mL to 200 ng/mL of the IS-mer peptide, and exposed to 30 f.1mollL FeS04 as mentioned above. One and one-half hours later, the neurons were lysed in a solution containing 15% trichloroacetic acid, 0.375% thiobarbituric acid (TBA; Wako, Osaka, Japan), 0.25 mol/L HCI, and 0.015% butylated hydroxy toluene (Wako centrifugation to remove flocculent precipitates, light absor bance at 535 nm was measured. The amount of TBA-reactive substances (TBARS) was calculated by using an extinction coefficient, 1.56 x 105 (mollL)-1 cm-I (Buege and Aust, 19S7).
In the study of hypoxic injury, cortical neurons were cultured with DMEM supplemented with 10% fetal calf serum for 24 hours as described above, and the culture medium was replaced with an IS-mer peptide-containing serum-free medium that was bubbled with nitrogen gas to remove dissolved oxygen gas beforehand. The neuronal cultures were incubated under an atmosphere of 95% N2 and 5% CO2 for 6 hours, followed by incubation for 1 hour under the conventional atmosphere con taining 5% CO2, Then 50 f.1L of the medium in each well was subjected to measurement of the activity of lactate dehydroge nase (LDH) leaked from damaged neurons by using a kit (Wako). Cytotoxicity was expressed by the ratio of LDH ac tivity in each well to that in the well of neurons completely lysed with Tween 20 19S5) .
Binding site of 18-mer peptide
The IS-mer peptide binding sites in the subcellular fractions of brain tissue were characterized with the BIAcore 2000TM system (Pharmacia Biotech AB, Uppsala, Sweden), which monitors real-time molecular interaction as detected by surface plasmon resonance phenomenon.
A 44-mer peptide sequence comprising the IS-mer peptide was selected from the rat saposin C domain as a ligand fixed to a sensor chip of the BIAcore system, as the IS-mer peptide was too small in molecular size to bind to the sensor chip. The 44-mer peptide (60 f.1g/mL) in 10 mmollL acetate buffer (pH 4.5) was immobilized to the sensor chip CM5 by the amine coupling method (Ward et a!., 1992). Another sensor chip de void of the immobilized ligand was used as a blank in control experiments.
The SP-SH rats with sham operation, those at the 1st and 7th days after MCA occlusion, were anesthetized with diethylether and transcardially perfused with saline (n = 4/group). The brain was removed and divided into the cerebral cortex and thalamus on ice. Both the membrane fraction and the synapto somal fraction were prepared according to the method of Gray and Whittaker (1962) with slight modifications. In brief, the brain was homogenized with a Teflon homogenizer in 0.32 mollL sucrose buffer. The homogenate was centrifuged at 1,000g for 10 minutes to obtain the crude nuclear fraction in the pellet. To remove the crude mitochondrial fraction, the super natant was centrifuged at 12,500g for 20 minutes, and the re sulting supernatant was ultracentrifuged at 100,000g for 60 minutes. The pellet was suspended in a modified BIAcore run ning buffer, which consisted of 10 mmol/L HEPES buffer (pH 7.4) containing 0.15 mollL NaCI, 3.4 mmollL ethylenediamine tetraacetate, and 0.1 % Tween-20, and ultracentrifuged at 100,000 g for 30 minutes. This final pellet suspended in the modified BIAcore running buffer was used as the membrane fraction. On the other hand, the crude nuclear fraction sus pended in 0.32 mollL sucrose was overlaid on two layers of O,S and 1.2 mollL sucrose and ultracentrifuged at 51 ,500g for 90 minutes in a swing rotor. The fraction collected from the in terface between O.S and 1.2 mollL sucrose layers was sus pended in the modified BIAcore running buffer and ultracen trifuged at 100,000g for 30 minutes. The resultant pellet sus pended in the modified BIAcore running buffer was used as the synaptosomal fraction.
Protein concentration of each fraction was adjusted to 0. week after MCA occlusion. The mean escape latency of ischemic rats treated with 20 ng/d or 60 ng/d of the 18-mer peptide was shorter than that of the vehicle-infused ischemic rats on the sec ond to fourth trial days. The peptide in a dose of 4 ng/d was less effective in shortening the escape latency. (8) Mean escape la tency at the 4th week after MCA occlusion. At this period the ischemic rats treated with 60 ng/d of the peptide showed a shorter response latency throughout the 4 trial days than did the vehicle-treated rats. *** P < 0.001, ** P < 0.01, and * P < 0.05, significantly different from the value of the vehicle-infused rats.
with BSA as a standard. Each sample was injected both to the peptide-immobili�ed chip and to the blank chip at a flow rate of 5 mUmin for 900 seconds. The next sample was injected after washing both chips with 200 mmollL glycine-Hel buffer (pH 2.7). The BIAcore sensorgram shows changes in response ex pressed as resonance units along the time after sample injec tion, and the maximal response was observed at 850 seconds. Therefore, we measured responses at 850 seconds, and binding quantity to the peptide was measured by subtracting response bound to the blank chip from that bound to the peptide immobilized chip.
Statistics
Experimental data were evaluated by the two-tailed Mann Whitney U test or by analysis of variance, followed by post hoc test (Scheffe's F). All data are presented as means ± SD.
RESULTS
Morris water maze tests at the 2nd week after MeA occlusion revealed that the mean escape latency of ve hicle-infused ischemic rats was significantly longer than that of sham-operated rats throughout the trial days. However, the mean escape latency of ischemic rats treated with 20 or 60 ng/day of the IS-mer peptide was shorter than that of the vehicle-infused ischemic rats on the 2nd to 4th trial days. The IS-mer peptide at a dose of 4 ng/day was less effective in shortening the escape la tency (Fig. lA) . At the 4th week after MeA occlusion, there was also a significant difference in the escape la tency between the vehicle-treated ischemic rats and the sham-operated rats. At this period, the ischemic rats treated with the IS-mer peptide at a dose of 60 ng/day exhibited a shorter escape latency than the vehicle infused ischemic rats throughout the 4 trial days (Fig.  I B) . The IS-mer peptide at a dose of 20 ng/day also reduced the escape latency significantly on the 2nd and 4th trial days. The MeA-occluded rats infused with 4 ng/day of the IS-mer peptide showed a significant im provement in the escape latency only on the 2nd trial day (Fig. I B) . There were no significant differences in swim ming speed among all the experimental groups (data not shown). The infusion of 60 ng/day of the IS-mer peptide did not significantly affect brain or body temperature during 7 hours after MeA occlusion ( Table 1) .
The left-to-right ratio of cerebrocortical area in ve hicle-infused ischemic rats was 6S.S ± 4.4%, whereas the ratios in MeA-occluded rats with IS-mer peptide treat ment at doses of 4, 20, and 60 ng/day were 76.S ± 2.9, S2.4 ± 3.5, and S4.S ± 3.9%, respectively. The ratio of the ischemic rats treated with 4, 20, or 60 ng/day of the IS-mer peptide was significantly larger than that of the vehicle-infused rats with MeA occlusion ( Fig. 2A) . The left-to-right ratio of thalamic area in the vehicle-infused ischemic rats was 78.2 ± 3.0%, whereas the ratios in MeA-occluded rats with the IS-mer peptide treatment at doses of 4, 20, and 60 ng/day were S7.7 ± 2.2, 9l.S ± 3.2, and 92.5 ± 2.5%, respectively. The IS-mer peptide at doses of 4 to 60 ng/day significantly prevented the sec ondary thalamic degeneration in MeA-occluded rats (Fig. 2B) .
In Nissl-stained sections, neurons in the VP thalamic nucleus of vehicle-infused ischemic rats were much fewer than those of sham-operated rats, and the vehicle treated thalamic neurons showed shrinkage of cell body at the 1st month after MeA occlusion ( Fig. 3A and B) . Treatment with the IS-mer peptide increased the number of VP thalamic neurons with normal morphological ap pearance (Fig. 3C) . Neuron counts using a computerized image-processing system revealed that significant num bers of VP thalamic neurons were rescued from second ary degeneration by treatment with 4 to 60 ng/day of the 18-mer peptide (Fig. 4) .
To characterize the neuroprotective action of the 18mer peptide ' in vitro, the peptide was applied to cultured cortical neurons exposed to or not exposed to FeS04. . 2. (A) The left-to-right ratio of cerebrocortical area in left MCA occluded rats with or without 18-mer peptide treatment. The ratios of isch emic rats treated with 4 to 60 ng/d of the peptide were significantly larger than the ratio of vehicle-infused isch emic rats. (8) The left-to-right ratio of thalamic area. The ratios of ischemic rats treated with all doses of the pep tide were larger than the ratio of ve hicle-infused ischemic rats. ** P < 0.01 and * P < 0.05, significantly different from the value of the vehicle-infused ischemic rats.
The neuronal viability was investigated by using western blotting with a monoclonal antibody specific to MAP2 in neurons (Fig. 5 ). MAP2 was apparently detected in the control cortical neurons [Fig. 5A , lane Fe 2+ ( -)] but was hardly detected in FeS04-treated neurons [Fig. 5A , lane Fe 2+ (+)]. When the 18-mer peptide was added to the culture medium beforehand, FeS04-induced neuron death was prevented at a rather narrow range of concen tration between 2 fg/mL and 2 pg/mL (Fig. 5A) . The neuroprotective effect of the 18-mer peptide against the lethal oxidative injury caused by FeS04 was quantita tively evaluated by densitometric analysis of the immu noreactive bands (Fig. 5B) . The results showed the neu rotrophism of the 18-mer peptide at concentrations of 2 fg/mL to 2 pg/mL. Furthermore, FeS04-induced lipid peroxidation as estimated by TBARS concentration was significantly attenuated by pretreatment with 2 to 200 fg/mL of the I8-mer peptide (Fig. 6) . The higher con centrations of the peptide did not reduce the production of TBARS by FeS04. The effective concentrations of the I8-mer peptide for reduction of lipid peroxidation were similar to those of the peptide as determined by the den sitometric analysis of MAP2-immunoreactive bands. Neuronal damage induced by hypoxic stress was as sessed by measuring the activity of LDH released from damaged neurons into culture medium (Fig. 7) . In the control neuron culture without hypoxic stress or I8-mer peptide treatment, the ratio of LDH activity to that in the Tween-20-treated culture was 2.5 ± 0.4%. Exposure of cortical neurons to a hypoxic environment increased the ratio of LDH activity up to 17.8 ± 2.3%. Treatment with the 18-mer peptide at concentrations of 200 pg/mL to 20 ng/mL significantly attenuated the hypoxic damage as evaluated by the LDH assays (Fig. 7) . Figure 8A shows the sensorgrams of a cortical synap tosome fraction to the blank chip and 44-mer peptide immobilized chip on the BIAcore system. Binding re sponse to the 44-mer peptide comprising the I8-mer pep- tide was expressed by subtracting the response to the blank chip from that to the 44-mer peptide-immobilized chip. Figure 8B shows changes in binding response to synaptosome and membrane fractions. Both the cortical and the thalamic membrane fractions exhibited no sig nificant changes in binding to the 44-mer peptide at the 1 st and 7th days after MCA occlusion. Binding of the cortical synaptosome to the 44-mer peptide significantly declined at the 1 st day after MCA occlusion and returned to a level close to the control value at the 7th day, whereas the synaptosome fraction of the thalamus did not show any changes in binding to the peptide in re sponse to MCA occlusion.
DISCUSSION
In developing the water maze task for the first time, Morris (1981) reported that experimental animals with a hippocampal lesion exhibit place navigation disability. However, Okada et al. (1995) showed the occurrence of long-term spatial cognitive impairment (i.e., place navi gation disability) in rats with MCA occlusion. We also showed that occlusion of the unilateral MCA above the rhinal fissure and distal to the striate branches in SP-SH rats causes place navigation disability (Zhang et a\., 1998) . Thus, several brain regions including the hippo campus and the cerebral cortex may be responsible for place navigation ability. Kumon et al. (1996) demon strated that permanent occlusion of the MCA distal to the striate branches in SP-SH rats causes place navigation disability that is ameliorated by cerebroventricular infu sion of CNTF. It is speculated at this moment that the amendment of place navigation disability is associated with a reduction by CNTF in the size of the primary ischemic lesion within the temporoparietal cortex. Like CNTF (Kumon et aI., 1996) , the 18-mer peptide infused into the cerebroventricles of MCA-occluded rats amelio rated the ischemia-induced place navigation disability and cortical infarction in the present study. However, one cannot exclude the possibility that thalamic neurons res cued by the 18-mer peptide infusion from secondary de-generation contribute to the amendment of place naviga tion disability in MCA-occluded rats. In support of this speculation, patients with cortical infarction after MCA occlusion develop dementia in association with the ret rograde thalamic degeneration (Tamura et aI., 1991) . The thalamus may act as a relay center to convey sensory information necessary for the acquisition and/or mainte nance of place navigation ability. If this is the case, the thalamus is likely to control the place-navigating behav ior of rats together with the cerebral cortex and hippo campus. We speculate that multiple brain nuclei such as the hippocampus, cerebral cortex, and the thalamus, which constitute complex neural circuits, are responsible for the occurrence of learning behavior, as suggested by Okada et ai. (1995) .
Upon permanent occlusion of the unilateral MCA dis tal to the striate branches, a part (ischemic core) of the temporoparietal cortex supplied by the MCA alone soon enters irreversible cerebral infarction. In contrast, an area surrounding the ischemic core (ischemic penumbra), even though blood supply from the MCA is terminated, begins to have a compensatory but insufficient blood supply possibly from dilated branches of the anterior and posterior cerebral arteries. It is likely that in the ischemic penumbra, where termination and insufficient resump tion of the blood supply take place, oxygen free radicals are generated to damage neurons in situ. If the blood brain barrier is disrupted in the ischemic penumbra, leu kocytes in the peripheral blood and/or tissue macro phages may also act as generators of oxygen free radicals i8-MER PEPTlDE REDUCES iSCHEMiC iNJURY 305 (Matsuo et ai., 1995) . In support of this speculation, Imaizumi et ai. (1990) reported that superoxide dismu tase-entrapped liposome attenuates cerebral infarction in rats with permanent occlusion of the MCA, suggesting that oxygen-derived free radicals are, at least in part, responsible not only for ischemiaireperfusion injuries (Siesjo, 1981; Siesjo and Bengtsson, 1989) but also for brain damage in rats with permanent MCA occlusion. In the present culture experiments, the 18-mer peptide at low concentrations (2 fg/mL to 2 pg/mL) protected cor tical neurons against oxidative injuries caused by the free radical-producing agent FeS04. On the other hand, the higher concentrations of the peptide (200 pg/mL to 20 ng/mL) attenuated neuronal damage elicited by hypoxic insult. Therefore, we speculate that at early postischemic periods when the concentration of the 18-mer peptide in brain extracellular spaces is <2 pg/mL, the peptide acts as an antioxidant agent, and that with accumulation of the peptide in the extracellular spaces, it protects cortical neurons against chronic hypoxic stress. However, this speculation must be verified in the future by a sensitive assay for the 18-mer peptide in the MCA-occluded brain.
Recently, cerami de has been shown to prevent neuro nal apoptosis induced by deprivation of nerve growth factor (Ito and Horigome, 1995) . Since saposin C acti vates sphingol,ipid hydrolase (acid l3-glucosidase) in ly sosome, ceramide is likely to be produced as a result of sphingolipid metabolism. However, the 18-mer peptide, even though being a fragment of saposin C that activates acid l3-glucosidase, does not act as a co-factor for the hydrolysis of glucosylceramide by the enzyme (Qi et ai., 1996) , and thus the possibility may be excluded that the 18-mer peptide rescues ischemic neurons through cer amide generation.
The molecular mechanisms underlying the neu rotrophism of the 18-mer peptide are unknown at pre sent. O'Brien et ai. (1994) have postulated the presence of a high-affinity prosaposin receptor on the surface of a neuroblastoma cell line, and prosaposin induces mito gen-activated protein kinase phosphorylation in PC 12 cells (Campana et ai., 1996) and in Schwann cells and oligodendrocytes (Hiraiwa et ai., 1997) . These findings support the notion that the 18-mer peptide also exerts a biological action through binding to a specific prosapo sin receptor. The present BIAcore analysis demonstrated that binding of the cellular membrane fraction to the 44-mer peptide fragment that composes the 18-mer pep tide was lower than that of the synaptosome fraction. This binding was eliminated by digestion of the synap tosome with trypsin (data not shown). These findings suggest that prosaposin receptor chiefly resides in the synaptosome. Furthermore, the binding response of the cortical synaptosome fraction to the 44-mer peptide sig nificantly declined at the 1st day after ischemia and re covered to the control level by the 7th day after ischemia. Therefore, in the early postischemic periods, endogenous prosaposin may be induced to bind to the receptor for neuronal survival, causing a transient decline in prosa posin receptor. Another possibility is that prosaposin re ceptor is down-regulated transiently after MCA occlu sion as a result of a decrease in total protein synthesis (Mies et ai., 1991) and subsequently up-regulated in sur viving neurons. Molecular cloning and characterization of prosaposin receptor would clarify the uncertain point of the present study.
